ReviewBiomedicines2021

A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking Studies.

Hyunwook Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.